ConductScience.org, home

Trial · NCT00047190

Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia

NCT00047190, Phase 2, Completed, National Cancer Institute (NCI)

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia. Trials, record NCT00047190. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00047190

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
NCT number
NCT00047190
Status
Completed
Phases
Phase 2
Enrollment
35 participants, actual
Lead sponsor
National Cancer Institute (NCI)
Conditions
Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis
Interventions
tipifarnib, laboratory biomarker analysis
First posted
2003-01-27
Last updated
2013-06-04

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryConfirmed response defined as the objective status of complete response (CR) or partial response (PR) on 2 consecutive evaluations at least 4 weeks apartUp to 2 yearsConfidence intervals for the true success proportion will be calculated according to the approach of Duffy and Santner.
SecondaryOverall survivalTime from registration to death due to any cause, assessed up to 2 yearsEstimated using the method of Kaplan-Meier.
SecondaryTime to progressionTime from registration to the time of progression, assessed up to 2 yearsEstimated using the method of Kaplan-Meier.
SecondaryDuration of responseDate of complete response to the date progression is documented (if one has occurred) or to the date of last follow-up (for those patients who have not progressed), assessed up to 2 years

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00047190

GET https://conductscience.org/api/trials/v1/NCT00047190/registered